128 related articles for article (PubMed ID: 38551726)
1. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together.
Wang TH; Wang HS; Soong YK
Cancer; 2000 Jun; 88(11):2619-28. PubMed ID: 10861441
[TBL] [Abstract][Full Text] [Related]
2. Interplay between paclitaxel, gap junctions, and kinases: unraveling mechanisms of action and resistance in cancer therapy.
Moon DO
Mol Biol Rep; 2024 Mar; 51(1):472. PubMed ID: 38551726
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cancer cell death induction by paclitaxel: an updated review.
Zhao S; Tang Y; Wang R; Najafi M
Apoptosis; 2022 Oct; 27(9-10):647-667. PubMed ID: 35849264
[TBL] [Abstract][Full Text] [Related]
4. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.
Podolski-Renić A; Banković J; Dinić J; Ríos-Luci C; Fernandes MX; Ortega N; Kovačević-Grujičić N; Martín VS; Padrón JM; Pešić M
Eur J Pharm Sci; 2017 Jul; 105():159-168. PubMed ID: 28502672
[TBL] [Abstract][Full Text] [Related]
5. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
7. Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7 / Taxol cells.
Gong W; Fang P; Leng M; Shi Y
PLoS One; 2023; 18(3):e0282244. PubMed ID: 36867605
[TBL] [Abstract][Full Text] [Related]
8. Analysis of exosomal competing endogenous RNA network response to paclitaxel treatment reveals key genes in advanced gastric cancer.
Lei J; Zhang G; Li D; Zhong J; Chen Q; Lin L; Liu Z
Front Oncol; 2022; 12():1027748. PubMed ID: 36387235
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel Regulates TRPA1 Function and Expression Through PKA and PKC.
Sánchez JC; Muñoz LV; Galindo-Márquez ML; Valencia-Vásquez A; García AM
Neurochem Res; 2023 Jan; 48(1):295-304. PubMed ID: 36098890
[TBL] [Abstract][Full Text] [Related]
10. Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis.
Cheng Z; Li Z; Gu L; Li L; Gao Q; Zhang X; Fu J; Guo Y; Li Q; Shen X; Chen M; Zhang X
J Cancer; 2022; 13(2):715-727. PubMed ID: 35069914
[TBL] [Abstract][Full Text] [Related]
11. The Chemistry of Nonclassical Taxane Diterpene.
Schneider F; Pan L; Ottenbruch M; List T; Gaich T
Acc Chem Res; 2021 May; 54(10):2347-2360. PubMed ID: 33942612
[TBL] [Abstract][Full Text] [Related]
12. Connexin 43 Modulates the Cellular Resistance to Paclitaxel via Targeting β-Tubulin in Triple-Negative Breast Cancer.
Fu Y; Sun X; Gu Z; Zhuang Z
Onco Targets Ther; 2020; 13():5323-5335. PubMed ID: 32606750
[TBL] [Abstract][Full Text] [Related]
13. Combinational treatment of gap junction enhancers and paclitaxel attenuates mammary tumor growth.
Shishido S; Nguyen TA
Anticancer Drugs; 2020 Apr; 31(4):353-358. PubMed ID: 31913199
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
